AIMS: Dependence on or problematic use of prescription drugs (PD) is estimated to be between 1 and 2% in the general population. In contrast, the proportion of substance-specific treatment in PD use disorders at 0.5% is comparatively low. With an estimated prevalence of 4.7%, PD-specific disorders are widespread in general hospitals compared to the general population. Brief intervention delivered in general hospitals might be useful to promote discontinuation or reduction of problematic prescription drug use. DESIGN: A randomized, controlled clinical trial. SETTING:Internal, surgical and gynaecological wards of a general and a university hospital. PARTICIPANTS: One hundred and twenty-six patients fulfilling criteria for either regular use of PD (more than 60 days within the last 3 months) or dependence on or abuse of PD, respectively, were allocated randomly to two conditions. INTERVENTION: Subjects received two counselling sessions based on Motivational Interviewing plus an individualized written feedback (intervention group, IG) or a booklet on health behaviour (control group, CG). MEASUREMENTS: The outcome was measured as reduction (>25%) and discontinuation of PD intake in terms of defined daily dosages (DDD). FINDINGS: After 3 months, more participants in the IG reduced their DDD compared to the participants in the CG (51.8% versus 30%; chi(2) = 6.17; P = 0.017). In the IG 17.9%, in the CG 8.6% discontinued use of PD (chi(2) = 2.42; P = 0.17). Conclusions Brief intervention based on Motivational Interviewing is effective in reducing PD intake in non-treatment-seeking patients.
RCT Entities:
AIMS: Dependence on or problematic use of prescription drugs (PD) is estimated to be between 1 and 2% in the general population. In contrast, the proportion of substance-specific treatment in PD use disorders at 0.5% is comparatively low. With an estimated prevalence of 4.7%, PD-specific disorders are widespread in general hospitals compared to the general population. Brief intervention delivered in general hospitals might be useful to promote discontinuation or reduction of problematic prescription drug use. DESIGN: A randomized, controlled clinical trial. SETTING: Internal, surgical and gynaecological wards of a general and a university hospital. PARTICIPANTS: One hundred and twenty-six patients fulfilling criteria for either regular use of PD (more than 60 days within the last 3 months) or dependence on or abuse of PD, respectively, were allocated randomly to two conditions. INTERVENTION: Subjects received two counselling sessions based on Motivational Interviewing plus an individualized written feedback (intervention group, IG) or a booklet on health behaviour (control group, CG). MEASUREMENTS: The outcome was measured as reduction (>25%) and discontinuation of PD intake in terms of defined daily dosages (DDD). FINDINGS: After 3 months, more participants in the IG reduced their DDD compared to the participants in the CG (51.8% versus 30%; chi(2) = 6.17; P = 0.017). In the IG 17.9%, in the CG 8.6% discontinued use of PD (chi(2) = 2.42; P = 0.17). Conclusions Brief intervention based on Motivational Interviewing is effective in reducing PD intake in non-treatment-seeking patients.
Authors: Adam J Gordon; Hillary V Kunins; Darius A Rastegar; Jeanette M Tetrault; Alexander Y Walley Journal: J Gen Intern Med Date: 2010-08-10 Impact factor: 5.128
Authors: Gerald Cochran; Adam J Gordon; Craig Field; Jennifer Bacci; Ranjita Dhital; Thomas Ylioja; Maxine Stitzer; Thomas Kelly; Ralph Tarter Journal: Res Social Adm Pharm Date: 2015-05-08
Authors: Aleksandra Zgierska; Iliya Paul Amaza; Richard L Brown; Marlon Mundt; Michael F Fleming Journal: J Fam Pract Date: 2014-09 Impact factor: 0.493
Authors: Adeline M Nyamathi; Karabi Nandy; Barbara Greengold; Mary Marfisee; Farinaz Khalilifard; Allan Cohen; Barbara Leake Journal: J Addict Dis Date: 2011-01
Authors: Richard Saitz; Daniel P Alford; Judith Bernstein; Debbie M Cheng; Jeffrey Samet; Tibor Palfai Journal: J Addict Med Date: 2010-09 Impact factor: 3.702
Authors: Robert P Schwartz; Jan Gryczynski; Shannon Gwin Mitchell; Arturo Gonzales; Ana Moseley; Thomas R Peterson; Steven J Ondersma; Kevin E O'Grady Journal: Addiction Date: 2014-03-10 Impact factor: 6.526
Authors: Richard Saitz; Tibor P A Palfai; Debbie M Cheng; Daniel P Alford; Judith A Bernstein; Christine A Lloyd-Travaglini; Seville M Meli; Christine E Chaisson; Jeffrey H Samet Journal: JAMA Date: 2014-08-06 Impact factor: 56.272
Authors: Peter Roy-Byrne; Kristin Bumgardner; Antoinette Krupski; Chris Dunn; Richard Ries; Dennis Donovan; Imara I West; Charles Maynard; David C Atkins; Meredith C Graves; Jutta M Joesch; Gary A Zarkin Journal: JAMA Date: 2014-08-06 Impact factor: 56.272